nodes	percent_of_prediction	percent_of_DWPC	metapath
Cysteamine—SST—nerve—skin cancer	0.05	0.163	CbGeAlD
Cysteamine—SST—blood vessel—skin cancer	0.0393	0.128	CbGeAlD
Cysteamine—NPY2R—head—skin cancer	0.0304	0.0992	CbGeAlD
Cysteamine—SST—neck—skin cancer	0.0281	0.0917	CbGeAlD
Cysteamine—SST—connective tissue—skin cancer	0.0201	0.0657	CbGeAlD
Cysteamine—SST—epithelium—skin cancer	0.0191	0.0624	CbGeAlD
Cysteamine—NPY2R—Peptide GPCRs—MC1R—skin cancer	0.0184	0.0846	CbGpPWpGaD
Cysteamine—MPO—endothelium—skin cancer	0.0172	0.056	CbGeAlD
Cysteamine—Gastrointestinal ulcer haemorrhage—Fluorouracil—skin cancer	0.017	0.0357	CcSEcCtD
Cysteamine—MPO—blood vessel—skin cancer	0.0158	0.0516	CbGeAlD
Cysteamine—SST—lymphoid tissue—skin cancer	0.0147	0.0481	CbGeAlD
Cysteamine—SST—female reproductive system—skin cancer	0.0142	0.0464	CbGeAlD
Cysteamine—Skin striae—Bleomycin—skin cancer	0.0132	0.0277	CcSEcCtD
Cysteamine—SST—head—skin cancer	0.0119	0.0387	CbGeAlD
Cysteamine—Phosphatase alkaline increased—Vismodegib—skin cancer	0.0112	0.0235	CcSEcCtD
Cysteamine—NPY2R—Circadian rythm related genes—NKX2-1—skin cancer	0.0102	0.0469	CbGpPWpGaD
Cysteamine—Blood alkaline phosphatase increased—Vismodegib—skin cancer	0.00934	0.0196	CcSEcCtD
Cysteamine—SST—Peptide ligand-binding receptors—MC1R—skin cancer	0.00903	0.0415	CbGpPWpGaD
Cysteamine—NPY2R—Peptide ligand-binding receptors—MC1R—skin cancer	0.00866	0.0398	CbGpPWpGaD
Cysteamine—SST—lymph node—skin cancer	0.00831	0.0271	CbGeAlD
Cysteamine—Pain in extremity—Vismodegib—skin cancer	0.00812	0.0171	CcSEcCtD
Cysteamine—MPO—connective tissue—skin cancer	0.00811	0.0265	CbGeAlD
Cysteamine—MPO—epithelium—skin cancer	0.0077	0.0251	CbGeAlD
Cysteamine—Dehydration—Vismodegib—skin cancer	0.00755	0.0159	CcSEcCtD
Cysteamine—MPO—skin of body—skin cancer	0.00732	0.0239	CbGeAlD
Cysteamine—Cerebral ischaemia—Temozolomide—skin cancer	0.00731	0.0154	CcSEcCtD
Cysteamine—NPY2R—GPCRs, Class A Rhodopsin-like—MC1R—skin cancer	0.00678	0.0311	CbGpPWpGaD
Cysteamine—SST—GPCR ligand binding—PTCH2—skin cancer	0.00638	0.0293	CbGpPWpGaD
Cysteamine—NPY2R—GPCR ligand binding—PTCH2—skin cancer	0.00612	0.0281	CbGpPWpGaD
Cysteamine—SST—Class A/1 (Rhodopsin-like receptors)—MC1R—skin cancer	0.00606	0.0278	CbGpPWpGaD
Cysteamine—MPO—lymphoid tissue—skin cancer	0.00593	0.0194	CbGeAlD
Cysteamine—NPY2R—Class A/1 (Rhodopsin-like receptors)—MC1R—skin cancer	0.00581	0.0267	CbGpPWpGaD
Cysteamine—Connective tissue disorder—Vismodegib—skin cancer	0.00552	0.0116	CcSEcCtD
Cysteamine—Encephalopathy—Fluorouracil—skin cancer	0.00507	0.0107	CcSEcCtD
Cysteamine—Pain in extremity—Vemurafenib—skin cancer	0.00502	0.0105	CcSEcCtD
Cysteamine—Hepatic function abnormal—Imiquimod—skin cancer	0.0049	0.0103	CcSEcCtD
Cysteamine—Malnutrition—Vismodegib—skin cancer	0.00489	0.0103	CcSEcCtD
Cysteamine—MPO—head—skin cancer	0.00478	0.0156	CbGeAlD
Cysteamine—Scotoma—Temozolomide—skin cancer	0.00465	0.00977	CcSEcCtD
Cysteamine—SST—GPCR ligand binding—MC1R—skin cancer	0.00461	0.0212	CbGpPWpGaD
Cysteamine—NPY2R—GPCRs, Class A Rhodopsin-like—PTGER4—skin cancer	0.00446	0.0205	CbGpPWpGaD
Cysteamine—NPY2R—GPCR ligand binding—MC1R—skin cancer	0.00442	0.0203	CbGpPWpGaD
Cysteamine—Lethargy—Imiquimod—skin cancer	0.00437	0.00917	CcSEcCtD
Cysteamine—Pain in extremity—Imiquimod—skin cancer	0.00428	0.00899	CcSEcCtD
Cysteamine—Unspecified disorder of skin and subcutaneous tissue—Vismodegib—skin cancer	0.00414	0.00869	CcSEcCtD
Cysteamine—SST—Class A/1 (Rhodopsin-like receptors)—PTGER4—skin cancer	0.00398	0.0183	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—RHOU—skin cancer	0.00396	0.0182	CbGpPWpGaD
Cysteamine—Nervous system disorder—Vismodegib—skin cancer	0.00391	0.00822	CcSEcCtD
Cysteamine—Skin disorder—Vismodegib—skin cancer	0.00388	0.00814	CcSEcCtD
Cysteamine—NPY2R—Class A/1 (Rhodopsin-like receptors)—PTGER4—skin cancer	0.00382	0.0175	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—RHOU—skin cancer	0.0038	0.0174	CbGpPWpGaD
Cysteamine—Phosphatase alkaline increased—Temozolomide—skin cancer	0.00353	0.00742	CcSEcCtD
Cysteamine—Dyspepsia—Vismodegib—skin cancer	0.00351	0.00738	CcSEcCtD
Cysteamine—Redness—Docetaxel—skin cancer	0.00348	0.00731	CcSEcCtD
Cysteamine—Decreased appetite—Vismodegib—skin cancer	0.00347	0.00729	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Vismodegib—skin cancer	0.00345	0.00724	CcSEcCtD
Cysteamine—Fatigue—Vismodegib—skin cancer	0.00344	0.00723	CcSEcCtD
Cysteamine—Constipation—Vismodegib—skin cancer	0.00341	0.00717	CcSEcCtD
Cysteamine—Connective tissue disorder—Vemurafenib—skin cancer	0.00341	0.00716	CcSEcCtD
Cysteamine—MPO—lymph node—skin cancer	0.00335	0.0109	CbGeAlD
Cysteamine—SST—GPCR ligand binding—SHH—skin cancer	0.00329	0.0151	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—PTCH2—skin cancer	0.00328	0.015	CbGpPWpGaD
Cysteamine—Gastrointestinal pain—Vismodegib—skin cancer	0.00326	0.00686	CcSEcCtD
Cysteamine—Abdominal pain—Vismodegib—skin cancer	0.00316	0.00663	CcSEcCtD
Cysteamine—NPY2R—GPCR ligand binding—SHH—skin cancer	0.00315	0.0145	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—PTCH2—skin cancer	0.00314	0.0144	CbGpPWpGaD
Cysteamine—SST—GPCR ligand binding—PTCH1—skin cancer	0.00312	0.0143	CbGpPWpGaD
Cysteamine—SST—GPCR ligand binding—SMO—skin cancer	0.00312	0.0143	CbGpPWpGaD
Cysteamine—Scotoma—Docetaxel—skin cancer	0.00309	0.0065	CcSEcCtD
Cysteamine—Mental disability—Temozolomide—skin cancer	0.00307	0.00644	CcSEcCtD
Cysteamine—SST—GPCR ligand binding—PTGER4—skin cancer	0.00303	0.0139	CbGpPWpGaD
Cysteamine—Erythema—Vemurafenib—skin cancer	0.00302	0.00635	CcSEcCtD
Cysteamine—Malnutrition—Vemurafenib—skin cancer	0.00302	0.00635	CcSEcCtD
Cysteamine—NPY2R—GPCR ligand binding—PTCH1—skin cancer	0.00299	0.0137	CbGpPWpGaD
Cysteamine—NPY2R—GPCR ligand binding—SMO—skin cancer	0.00299	0.0137	CbGpPWpGaD
Cysteamine—Blood alkaline phosphatase increased—Temozolomide—skin cancer	0.00295	0.00619	CcSEcCtD
Cysteamine—Urinary tract disorder—Imiquimod—skin cancer	0.00292	0.00614	CcSEcCtD
Cysteamine—NPY2R—GPCR ligand binding—PTGER4—skin cancer	0.00291	0.0134	CbGpPWpGaD
Cysteamine—Connective tissue disorder—Imiquimod—skin cancer	0.00291	0.00611	CcSEcCtD
Cysteamine—Urethral disorder—Imiquimod—skin cancer	0.0029	0.0061	CcSEcCtD
Cysteamine—Lethargy—Dactinomycin—skin cancer	0.00289	0.00608	CcSEcCtD
Cysteamine—Gastroenteritis—Temozolomide—skin cancer	0.00289	0.00608	CcSEcCtD
Cysteamine—NPY2R—Circadian rythm related genes—CDK4—skin cancer	0.00288	0.0132	CbGpPWpGaD
Cysteamine—Asthenia—Vismodegib—skin cancer	0.00286	0.00602	CcSEcCtD
Cysteamine—Eye pain—Temozolomide—skin cancer	0.00284	0.00597	CcSEcCtD
Cysteamine—Diarrhoea—Vismodegib—skin cancer	0.00273	0.00574	CcSEcCtD
Cysteamine—Immune system disorder—Imiquimod—skin cancer	0.00267	0.00562	CcSEcCtD
Cysteamine—Liver function test abnormal—Dactinomycin—skin cancer	0.00262	0.0055	CcSEcCtD
Cysteamine—SST—GPCR downstream signaling—MC1R—skin cancer	0.00261	0.012	CbGpPWpGaD
Cysteamine—Bone disorder—Docetaxel—skin cancer	0.0026	0.00546	CcSEcCtD
Cysteamine—Mental disorder—Imiquimod—skin cancer	0.00259	0.00545	CcSEcCtD
Cysteamine—Malnutrition—Imiquimod—skin cancer	0.00258	0.00541	CcSEcCtD
Cysteamine—Erythema—Imiquimod—skin cancer	0.00258	0.00541	CcSEcCtD
Cysteamine—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—skin cancer	0.00255	0.00537	CcSEcCtD
Cysteamine—Vomiting—Vismodegib—skin cancer	0.00254	0.00533	CcSEcCtD
Cysteamine—Affect lability—Temozolomide—skin cancer	0.00252	0.0053	CcSEcCtD
Cysteamine—Rash—Vismodegib—skin cancer	0.00252	0.00529	CcSEcCtD
Cysteamine—Dermatitis—Vismodegib—skin cancer	0.00251	0.00528	CcSEcCtD
Cysteamine—NPY2R—GPCR downstream signaling—MC1R—skin cancer	0.0025	0.0115	CbGpPWpGaD
Cysteamine—Anaphylactic shock—Vemurafenib—skin cancer	0.00247	0.00518	CcSEcCtD
Cysteamine—Mood swings—Temozolomide—skin cancer	0.00243	0.0051	CcSEcCtD
Cysteamine—Nervous system disorder—Vemurafenib—skin cancer	0.00242	0.00508	CcSEcCtD
Cysteamine—Ataxia—Temozolomide—skin cancer	0.00241	0.00506	CcSEcCtD
Cysteamine—Lethargy—Fluorouracil—skin cancer	0.00241	0.00506	CcSEcCtD
Cysteamine—Skin disorder—Vemurafenib—skin cancer	0.0024	0.00503	CcSEcCtD
Cysteamine—Dehydration—Temozolomide—skin cancer	0.00238	0.00501	CcSEcCtD
Cysteamine—Nausea—Vismodegib—skin cancer	0.00237	0.00498	CcSEcCtD
Cysteamine—SST—Signaling by GPCR—MC1R—skin cancer	0.00237	0.0109	CbGpPWpGaD
Cysteamine—Agitation—Imiquimod—skin cancer	0.00237	0.00497	CcSEcCtD
Cysteamine—Phosphatase alkaline increased—Docetaxel—skin cancer	0.00235	0.00493	CcSEcCtD
Cysteamine—NPY2R—Signaling by GPCR—MC1R—skin cancer	0.00227	0.0104	CbGpPWpGaD
Cysteamine—Convulsion—Imiquimod—skin cancer	0.00223	0.00469	CcSEcCtD
Cysteamine—Hypertension—Imiquimod—skin cancer	0.00222	0.00467	CcSEcCtD
Cysteamine—Ataxia—Fluorouracil—skin cancer	0.00222	0.00467	CcSEcCtD
Cysteamine—Unspecified disorder of skin and subcutaneous tissue—Imiquimod—skin cancer	0.00218	0.00458	CcSEcCtD
Cysteamine—Discomfort—Imiquimod—skin cancer	0.00217	0.00455	CcSEcCtD
Cysteamine—Decreased appetite—Vemurafenib—skin cancer	0.00214	0.0045	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Vemurafenib—skin cancer	0.00213	0.00447	CcSEcCtD
Cysteamine—Fatigue—Vemurafenib—skin cancer	0.00213	0.00447	CcSEcCtD
Cysteamine—Constipation—Vemurafenib—skin cancer	0.00211	0.00443	CcSEcCtD
Cysteamine—Nervous system disorder—Imiquimod—skin cancer	0.00206	0.00433	CcSEcCtD
Cysteamine—Skin disorder—Imiquimod—skin cancer	0.00204	0.00429	CcSEcCtD
Cysteamine—Anorexia—Imiquimod—skin cancer	0.002	0.00421	CcSEcCtD
Cysteamine—Blood alkaline phosphatase increased—Docetaxel—skin cancer	0.00196	0.00412	CcSEcCtD
Cysteamine—Body temperature increased—Vemurafenib—skin cancer	0.00195	0.0041	CcSEcCtD
Cysteamine—SST—Signaling Pathways—PTCH2—skin cancer	0.00193	0.00889	CbGpPWpGaD
Cysteamine—Somnolence—Imiquimod—skin cancer	0.00187	0.00393	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—PTCH2—skin cancer	0.00186	0.00852	CbGpPWpGaD
Cysteamine—Dyspepsia—Imiquimod—skin cancer	0.00185	0.00389	CcSEcCtD
Cysteamine—MPO—C-MYB transcription factor network—CDKN2A—skin cancer	0.00183	0.00842	CbGpPWpGaD
Cysteamine—Erythema—Bleomycin—skin cancer	0.00183	0.00385	CcSEcCtD
Cysteamine—Decreased appetite—Imiquimod—skin cancer	0.00183	0.00384	CcSEcCtD
Cysteamine—Hypersensitivity—Vemurafenib—skin cancer	0.00182	0.00382	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Imiquimod—skin cancer	0.00182	0.00381	CcSEcCtD
Cysteamine—Fatigue—Imiquimod—skin cancer	0.00181	0.00381	CcSEcCtD
Cysteamine—MPO—IL23-mediated signaling events—IL6—skin cancer	0.0018	0.00827	CbGpPWpGaD
Cysteamine—Asthenia—Vemurafenib—skin cancer	0.00177	0.00372	CcSEcCtD
Cysteamine—Hallucination—Temozolomide—skin cancer	0.00176	0.00371	CcSEcCtD
Cysteamine—Urinary tract disorder—Temozolomide—skin cancer	0.00175	0.00368	CcSEcCtD
Cysteamine—Connective tissue disorder—Temozolomide—skin cancer	0.00174	0.00366	CcSEcCtD
Cysteamine—Lethargy—Docetaxel—skin cancer	0.00174	0.00366	CcSEcCtD
Cysteamine—Urethral disorder—Temozolomide—skin cancer	0.00174	0.00365	CcSEcCtD
Cysteamine—Feeling abnormal—Imiquimod—skin cancer	0.00173	0.00364	CcSEcCtD
Cysteamine—Gastrointestinal pain—Imiquimod—skin cancer	0.00172	0.00361	CcSEcCtD
Cysteamine—MPO—C-MYB transcription factor network—PTGS2—skin cancer	0.00171	0.00788	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—PTGER4—skin cancer	0.00171	0.00788	CbGpPWpGaD
Cysteamine—Erythema—Dactinomycin—skin cancer	0.00171	0.00359	CcSEcCtD
Cysteamine—Pain in extremity—Docetaxel—skin cancer	0.00171	0.00358	CcSEcCtD
Cysteamine—Anaemia—Bleomycin—skin cancer	0.00169	0.00355	CcSEcCtD
Cysteamine—SST—Signaling by GPCR—SHH—skin cancer	0.00169	0.00775	CbGpPWpGaD
Cysteamine—Diarrhoea—Vemurafenib—skin cancer	0.00169	0.00354	CcSEcCtD
Cysteamine—Urticaria—Imiquimod—skin cancer	0.00167	0.00351	CcSEcCtD
Cysteamine—Abdominal pain—Imiquimod—skin cancer	0.00166	0.00349	CcSEcCtD
Cysteamine—Body temperature increased—Imiquimod—skin cancer	0.00166	0.00349	CcSEcCtD
Cysteamine—MPO—Selenium Micronutrient Network—PTGS2—skin cancer	0.00165	0.00759	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—PTGER4—skin cancer	0.00164	0.00755	CbGpPWpGaD
Cysteamine—Leukopenia—Bleomycin—skin cancer	0.00164	0.00344	CcSEcCtD
Cysteamine—Dizziness—Vemurafenib—skin cancer	0.00163	0.00343	CcSEcCtD
Cysteamine—NPY2R—Signaling by GPCR—SHH—skin cancer	0.00162	0.00743	CbGpPWpGaD
Cysteamine—Ataxia—Docetaxel—skin cancer	0.0016	0.00337	CcSEcCtD
Cysteamine—Immune system disorder—Temozolomide—skin cancer	0.0016	0.00337	CcSEcCtD
Cysteamine—SST—Signaling by GPCR—PTCH1—skin cancer	0.0016	0.00735	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—SMO—skin cancer	0.0016	0.00735	CbGpPWpGaD
Cysteamine—Dehydration—Docetaxel—skin cancer	0.00159	0.00333	CcSEcCtD
Cysteamine—Anaemia—Dactinomycin—skin cancer	0.00158	0.00331	CcSEcCtD
Cysteamine—Liver function test abnormal—Docetaxel—skin cancer	0.00157	0.00331	CcSEcCtD
Cysteamine—Vomiting—Vemurafenib—skin cancer	0.00157	0.00329	CcSEcCtD
Cysteamine—SST—Signaling by GPCR—PTGER4—skin cancer	0.00156	0.00715	CbGpPWpGaD
Cysteamine—Rash—Vemurafenib—skin cancer	0.00155	0.00327	CcSEcCtD
Cysteamine—Mental disorder—Temozolomide—skin cancer	0.00155	0.00326	CcSEcCtD
Cysteamine—Dermatitis—Vemurafenib—skin cancer	0.00155	0.00326	CcSEcCtD
Cysteamine—Hypersensitivity—Imiquimod—skin cancer	0.00155	0.00325	CcSEcCtD
Cysteamine—Headache—Vemurafenib—skin cancer	0.00154	0.00325	CcSEcCtD
Cysteamine—Erythema—Temozolomide—skin cancer	0.00154	0.00324	CcSEcCtD
Cysteamine—Malnutrition—Temozolomide—skin cancer	0.00154	0.00324	CcSEcCtD
Cysteamine—Discomfort—Bleomycin—skin cancer	0.00154	0.00323	CcSEcCtD
Cysteamine—NPY2R—Signaling by GPCR—PTCH1—skin cancer	0.00153	0.00704	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—SMO—skin cancer	0.00153	0.00704	CbGpPWpGaD
Cysteamine—Leukopenia—Dactinomycin—skin cancer	0.00153	0.00321	CcSEcCtD
Cysteamine—Asthenia—Imiquimod—skin cancer	0.00151	0.00317	CcSEcCtD
Cysteamine—Confusional state—Bleomycin—skin cancer	0.00151	0.00316	CcSEcCtD
Cysteamine—Anaphylactic shock—Bleomycin—skin cancer	0.00149	0.00314	CcSEcCtD
Cysteamine—NPY2R—Signaling by GPCR—PTGER4—skin cancer	0.00149	0.00686	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—GLI2—skin cancer	0.00147	0.00674	CbGpPWpGaD
Cysteamine—Nausea—Vemurafenib—skin cancer	0.00146	0.00308	CcSEcCtD
Cysteamine—Tremor—Temozolomide—skin cancer	0.00145	0.00304	CcSEcCtD
Cysteamine—Diarrhoea—Imiquimod—skin cancer	0.00144	0.00302	CcSEcCtD
Cysteamine—Discomfort—Dactinomycin—skin cancer	0.00144	0.00302	CcSEcCtD
Cysteamine—SST—SIDS Susceptibility Pathways—IL6—skin cancer	0.00143	0.00657	CbGpPWpGaD
Cysteamine—Anaemia—Temozolomide—skin cancer	0.00143	0.003	CcSEcCtD
Cysteamine—Anorexia—Bleomycin—skin cancer	0.00142	0.00299	CcSEcCtD
Cysteamine—Erythema—Fluorouracil—skin cancer	0.00142	0.00299	CcSEcCtD
Cysteamine—Agitation—Temozolomide—skin cancer	0.00142	0.00298	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—GLI2—skin cancer	0.00141	0.00646	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—MC1R—skin cancer	0.0014	0.00643	CbGpPWpGaD
Cysteamine—MPO—Vitamin B12 Metabolism—IL6—skin cancer	0.00139	0.0064	CbGpPWpGaD
Cysteamine—Dizziness—Imiquimod—skin cancer	0.00139	0.00292	CcSEcCtD
Cysteamine—Leukopenia—Temozolomide—skin cancer	0.00138	0.0029	CcSEcCtD
Cysteamine—SST—Signaling Pathways—GLI1—skin cancer	0.00138	0.00633	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—MC1R—skin cancer	0.00134	0.00616	CbGpPWpGaD
Cysteamine—Convulsion—Temozolomide—skin cancer	0.00134	0.00281	CcSEcCtD
Cysteamine—Vomiting—Imiquimod—skin cancer	0.00134	0.00281	CcSEcCtD
Cysteamine—MPO—C-MYB transcription factor network—NRAS—skin cancer	0.00133	0.00613	CbGpPWpGaD
Cysteamine—Hypertension—Temozolomide—skin cancer	0.00133	0.0028	CcSEcCtD
Cysteamine—Anorexia—Dactinomycin—skin cancer	0.00133	0.00279	CcSEcCtD
Cysteamine—Rash—Imiquimod—skin cancer	0.00133	0.00279	CcSEcCtD
Cysteamine—Dermatitis—Imiquimod—skin cancer	0.00132	0.00278	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—GLI1—skin cancer	0.00132	0.00607	CbGpPWpGaD
Cysteamine—Headache—Imiquimod—skin cancer	0.00132	0.00277	CcSEcCtD
Cysteamine—Anaemia—Fluorouracil—skin cancer	0.00132	0.00276	CcSEcCtD
Cysteamine—SST—Signaling Pathways—SUFU—skin cancer	0.00131	0.006	CbGpPWpGaD
Cysteamine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.00131	0.00274	CcSEcCtD
Cysteamine—Discomfort—Temozolomide—skin cancer	0.0013	0.00273	CcSEcCtD
Cysteamine—Decreased appetite—Bleomycin—skin cancer	0.0013	0.00273	CcSEcCtD
Cysteamine—Renal failure—Docetaxel—skin cancer	0.00129	0.00271	CcSEcCtD
Cysteamine—Leukopenia—Fluorouracil—skin cancer	0.00127	0.00268	CcSEcCtD
Cysteamine—Confusional state—Temozolomide—skin cancer	0.00127	0.00267	CcSEcCtD
Cysteamine—Anaphylactic shock—Temozolomide—skin cancer	0.00126	0.00265	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—SUFU—skin cancer	0.00125	0.00576	CbGpPWpGaD
Cysteamine—Nausea—Imiquimod—skin cancer	0.00125	0.00262	CcSEcCtD
Cysteamine—MPO—Folate Metabolism—TP53—skin cancer	0.00124	0.00569	CbGpPWpGaD
Cysteamine—Nervous system disorder—Temozolomide—skin cancer	0.00124	0.0026	CcSEcCtD
Cysteamine—Convulsion—Fluorouracil—skin cancer	0.00123	0.00259	CcSEcCtD
Cysteamine—Feeling abnormal—Bleomycin—skin cancer	0.00123	0.00259	CcSEcCtD
Cysteamine—Skin disorder—Temozolomide—skin cancer	0.00122	0.00257	CcSEcCtD
Cysteamine—NPY2R—Circadian rythm related genes—TP53—skin cancer	0.00122	0.00562	CbGpPWpGaD
Cysteamine—Decreased appetite—Dactinomycin—skin cancer	0.00121	0.00254	CcSEcCtD
Cysteamine—Fatigue—Dactinomycin—skin cancer	0.0012	0.00252	CcSEcCtD
Cysteamine—Anorexia—Temozolomide—skin cancer	0.0012	0.00252	CcSEcCtD
Cysteamine—Discomfort—Fluorouracil—skin cancer	0.0012	0.00251	CcSEcCtD
Cysteamine—Urticaria—Bleomycin—skin cancer	0.00119	0.00249	CcSEcCtD
Cysteamine—Body temperature increased—Bleomycin—skin cancer	0.00118	0.00248	CcSEcCtD
Cysteamine—Confusional state—Fluorouracil—skin cancer	0.00117	0.00246	CcSEcCtD
Cysteamine—Urinary tract disorder—Docetaxel—skin cancer	0.00116	0.00245	CcSEcCtD
Cysteamine—Anaphylactic shock—Fluorouracil—skin cancer	0.00116	0.00244	CcSEcCtD
Cysteamine—Connective tissue disorder—Docetaxel—skin cancer	0.00116	0.00244	CcSEcCtD
Cysteamine—Urethral disorder—Docetaxel—skin cancer	0.00116	0.00243	CcSEcCtD
Cysteamine—MPO—C-MYB transcription factor network—KRAS—skin cancer	0.00115	0.00527	CbGpPWpGaD
Cysteamine—Feeling abnormal—Dactinomycin—skin cancer	0.00115	0.00241	CcSEcCtD
Cysteamine—Gastrointestinal pain—Dactinomycin—skin cancer	0.00114	0.00239	CcSEcCtD
Cysteamine—Nervous system disorder—Fluorouracil—skin cancer	0.00114	0.00239	CcSEcCtD
Cysteamine—MPO—Folate Metabolism—IL6—skin cancer	0.00113	0.0052	CbGpPWpGaD
Cysteamine—Somnolence—Temozolomide—skin cancer	0.00112	0.00235	CcSEcCtD
Cysteamine—NPY2R—Circadian rythm related genes—IL6—skin cancer	0.00112	0.00514	CbGpPWpGaD
Cysteamine—Dyspepsia—Temozolomide—skin cancer	0.00111	0.00233	CcSEcCtD
Cysteamine—Anorexia—Fluorouracil—skin cancer	0.00111	0.00233	CcSEcCtD
Cysteamine—Body temperature increased—Dactinomycin—skin cancer	0.0011	0.00231	CcSEcCtD
Cysteamine—Abdominal pain—Dactinomycin—skin cancer	0.0011	0.00231	CcSEcCtD
Cysteamine—Hypersensitivity—Bleomycin—skin cancer	0.0011	0.00231	CcSEcCtD
Cysteamine—Decreased appetite—Temozolomide—skin cancer	0.0011	0.0023	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Temozolomide—skin cancer	0.00109	0.00229	CcSEcCtD
Cysteamine—Fatigue—Temozolomide—skin cancer	0.00109	0.00228	CcSEcCtD
Cysteamine—Constipation—Temozolomide—skin cancer	0.00108	0.00226	CcSEcCtD
Cysteamine—Asthenia—Bleomycin—skin cancer	0.00107	0.00225	CcSEcCtD
Cysteamine—Immune system disorder—Docetaxel—skin cancer	0.00107	0.00224	CcSEcCtD
Cysteamine—Feeling abnormal—Temozolomide—skin cancer	0.00104	0.00218	CcSEcCtD
Cysteamine—Mental disorder—Docetaxel—skin cancer	0.00103	0.00217	CcSEcCtD
Cysteamine—Somnolence—Fluorouracil—skin cancer	0.00103	0.00217	CcSEcCtD
Cysteamine—Gastrointestinal pain—Temozolomide—skin cancer	0.00103	0.00216	CcSEcCtD
Cysteamine—Erythema—Docetaxel—skin cancer	0.00103	0.00216	CcSEcCtD
Cysteamine—Malnutrition—Docetaxel—skin cancer	0.00103	0.00216	CcSEcCtD
Cysteamine—Hypersensitivity—Dactinomycin—skin cancer	0.00103	0.00216	CcSEcCtD
Cysteamine—Dyspepsia—Fluorouracil—skin cancer	0.00102	0.00215	CcSEcCtD
Cysteamine—Decreased appetite—Fluorouracil—skin cancer	0.00101	0.00212	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Fluorouracil—skin cancer	0.001	0.00211	CcSEcCtD
Cysteamine—Urticaria—Temozolomide—skin cancer	0.001	0.0021	CcSEcCtD
Cysteamine—Asthenia—Dactinomycin—skin cancer	0.001	0.0021	CcSEcCtD
Cysteamine—SST—Signaling Pathways—SHH—skin cancer	0.000997	0.00458	CbGpPWpGaD
Cysteamine—Abdominal pain—Temozolomide—skin cancer	0.000996	0.00209	CcSEcCtD
Cysteamine—Body temperature increased—Temozolomide—skin cancer	0.000996	0.00209	CcSEcCtD
Cysteamine—SST—Signaling Pathways—RASA1—skin cancer	0.00099	0.00455	CbGpPWpGaD
Cysteamine—MPO—C-MYB transcription factor network—HRAS—skin cancer	0.000976	0.00448	CbGpPWpGaD
Cysteamine—Feeling abnormal—Fluorouracil—skin cancer	0.000957	0.00201	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—SHH—skin cancer	0.000956	0.00439	CbGpPWpGaD
Cysteamine—Diarrhoea—Dactinomycin—skin cancer	0.000953	0.002	CcSEcCtD
Cysteamine—Vomiting—Bleomycin—skin cancer	0.00095	0.002	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—RASA1—skin cancer	0.00095	0.00436	CbGpPWpGaD
Cysteamine—Anaemia—Docetaxel—skin cancer	0.000949	0.00199	CcSEcCtD
Cysteamine—SST—Signaling Pathways—PTCH1—skin cancer	0.000945	0.00434	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—SMO—skin cancer	0.000945	0.00434	CbGpPWpGaD
Cysteamine—Rash—Bleomycin—skin cancer	0.000942	0.00198	CcSEcCtD
Cysteamine—Dermatitis—Bleomycin—skin cancer	0.000941	0.00198	CcSEcCtD
Cysteamine—Hypersensitivity—Temozolomide—skin cancer	0.000929	0.00195	CcSEcCtD
Cysteamine—Urticaria—Fluorouracil—skin cancer	0.000922	0.00194	CcSEcCtD
Cysteamine—SST—Signaling Pathways—PTGER4—skin cancer	0.00092	0.00423	CbGpPWpGaD
Cysteamine—Leukopenia—Docetaxel—skin cancer	0.000919	0.00193	CcSEcCtD
Cysteamine—Body temperature increased—Fluorouracil—skin cancer	0.000918	0.00193	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—SMO—skin cancer	0.000906	0.00416	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—PTCH1—skin cancer	0.000906	0.00416	CbGpPWpGaD
Cysteamine—Asthenia—Temozolomide—skin cancer	0.000904	0.0019	CcSEcCtD
Cysteamine—MPO—Selenium Micronutrient Network—IL6—skin cancer	0.0009	0.00413	CbGpPWpGaD
Cysteamine—Convulsion—Docetaxel—skin cancer	0.00089	0.00187	CcSEcCtD
Cysteamine—Nausea—Bleomycin—skin cancer	0.000887	0.00186	CcSEcCtD
Cysteamine—Hypertension—Docetaxel—skin cancer	0.000887	0.00186	CcSEcCtD
Cysteamine—Vomiting—Dactinomycin—skin cancer	0.000886	0.00186	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—PTGER4—skin cancer	0.000882	0.00405	CbGpPWpGaD
Cysteamine—Rash—Dactinomycin—skin cancer	0.000879	0.00185	CcSEcCtD
Cysteamine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.000868	0.00182	CcSEcCtD
Cysteamine—Diarrhoea—Temozolomide—skin cancer	0.000862	0.00181	CcSEcCtD
Cysteamine—Hypersensitivity—Fluorouracil—skin cancer	0.000856	0.0018	CcSEcCtD
Cysteamine—Confusional state—Docetaxel—skin cancer	0.000845	0.00178	CcSEcCtD
Cysteamine—Anaphylactic shock—Docetaxel—skin cancer	0.000838	0.00176	CcSEcCtD
Cysteamine—Dizziness—Temozolomide—skin cancer	0.000833	0.00175	CcSEcCtD
Cysteamine—Nausea—Dactinomycin—skin cancer	0.000828	0.00174	CcSEcCtD
Cysteamine—Nervous system disorder—Docetaxel—skin cancer	0.000822	0.00173	CcSEcCtD
Cysteamine—Skin disorder—Docetaxel—skin cancer	0.000814	0.00171	CcSEcCtD
Cysteamine—SST—Signaling Pathways—FOXO4—skin cancer	0.000813	0.00373	CbGpPWpGaD
Cysteamine—Vomiting—Temozolomide—skin cancer	0.000801	0.00168	CcSEcCtD
Cysteamine—Anorexia—Docetaxel—skin cancer	0.000799	0.00168	CcSEcCtD
Cysteamine—Rash—Temozolomide—skin cancer	0.000795	0.00167	CcSEcCtD
Cysteamine—Diarrhoea—Fluorouracil—skin cancer	0.000794	0.00167	CcSEcCtD
Cysteamine—Dermatitis—Temozolomide—skin cancer	0.000794	0.00167	CcSEcCtD
Cysteamine—Headache—Temozolomide—skin cancer	0.00079	0.00166	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—FOXO4—skin cancer	0.000779	0.00358	CbGpPWpGaD
Cysteamine—Dizziness—Fluorouracil—skin cancer	0.000768	0.00161	CcSEcCtD
Cysteamine—Nausea—Temozolomide—skin cancer	0.000749	0.00157	CcSEcCtD
Cysteamine—Somnolence—Docetaxel—skin cancer	0.000745	0.00157	CcSEcCtD
Cysteamine—Vomiting—Fluorouracil—skin cancer	0.000738	0.00155	CcSEcCtD
Cysteamine—Dyspepsia—Docetaxel—skin cancer	0.000738	0.00155	CcSEcCtD
Cysteamine—Rash—Fluorouracil—skin cancer	0.000732	0.00154	CcSEcCtD
Cysteamine—Dermatitis—Fluorouracil—skin cancer	0.000731	0.00154	CcSEcCtD
Cysteamine—Decreased appetite—Docetaxel—skin cancer	0.000729	0.00153	CcSEcCtD
Cysteamine—Headache—Fluorouracil—skin cancer	0.000727	0.00153	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Docetaxel—skin cancer	0.000724	0.00152	CcSEcCtD
Cysteamine—Fatigue—Docetaxel—skin cancer	0.000723	0.00152	CcSEcCtD
Cysteamine—Constipation—Docetaxel—skin cancer	0.000717	0.00151	CcSEcCtD
Cysteamine—Feeling abnormal—Docetaxel—skin cancer	0.000691	0.00145	CcSEcCtD
Cysteamine—Nausea—Fluorouracil—skin cancer	0.00069	0.00145	CcSEcCtD
Cysteamine—Gastrointestinal pain—Docetaxel—skin cancer	0.000685	0.00144	CcSEcCtD
Cysteamine—Abdominal pain—Docetaxel—skin cancer	0.000663	0.00139	CcSEcCtD
Cysteamine—Body temperature increased—Docetaxel—skin cancer	0.000663	0.00139	CcSEcCtD
Cysteamine—Hypersensitivity—Docetaxel—skin cancer	0.000617	0.0013	CcSEcCtD
Cysteamine—Asthenia—Docetaxel—skin cancer	0.000601	0.00126	CcSEcCtD
Cysteamine—Diarrhoea—Docetaxel—skin cancer	0.000573	0.0012	CcSEcCtD
Cysteamine—Dizziness—Docetaxel—skin cancer	0.000554	0.00116	CcSEcCtD
Cysteamine—SST—Signaling Pathways—TERT—skin cancer	0.000543	0.00249	CbGpPWpGaD
Cysteamine—Vomiting—Docetaxel—skin cancer	0.000533	0.00112	CcSEcCtD
Cysteamine—Rash—Docetaxel—skin cancer	0.000528	0.00111	CcSEcCtD
Cysteamine—Dermatitis—Docetaxel—skin cancer	0.000528	0.00111	CcSEcCtD
Cysteamine—Headache—Docetaxel—skin cancer	0.000525	0.0011	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—TERT—skin cancer	0.00052	0.00239	CbGpPWpGaD
Cysteamine—Nausea—Docetaxel—skin cancer	0.000498	0.00105	CcSEcCtD
Cysteamine—SST—Signaling by GPCR—NRAS—skin cancer	0.000457	0.0021	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—NRAS—skin cancer	0.000438	0.00201	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—BRAF—skin cancer	0.00043	0.00197	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—BRAF—skin cancer	0.000412	0.00189	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—KRAS—skin cancer	0.000394	0.00181	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—KRAS—skin cancer	0.000377	0.00173	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—HRAS—skin cancer	0.000335	0.00154	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—HRAS—skin cancer	0.000321	0.00147	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—IL6—skin cancer	0.00032	0.00147	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—IL6—skin cancer	0.000307	0.00141	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—NRAS—skin cancer	0.00027	0.00124	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—NRAS—skin cancer	0.000259	0.00119	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—KRAS—skin cancer	0.000232	0.00107	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—KRAS—skin cancer	0.000223	0.00102	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—TP53—skin cancer	0.000207	0.000949	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—TP53—skin cancer	0.000198	0.00091	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—HRAS—skin cancer	0.000198	0.000908	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—HRAS—skin cancer	0.000189	0.00087	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—IL6—skin cancer	0.000189	0.000869	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—IL6—skin cancer	0.000181	0.000833	CbGpPWpGaD
